193 related articles for article (PubMed ID: 16957799)
1. Treating the right patient at the right time: access to cardiovascular nuclear imaging.
Gulenchyn KY; McEwan AJ; Freeman M; Kiess M; O'Neill BJ; Beanlands RS; ;
Can J Cardiol; 2006 Aug; 22(10):827-33. PubMed ID: 16957799
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
5. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
[TBL] [Abstract][Full Text] [Related]
6. Universal access: but when? Treating the right patient at the right time: access to cardiac rehabilitation.
Dafoe W; Arthur H; Stokes H; Morrin L; Beaton L;
Can J Cardiol; 2006 Sep; 22(11):905-11. PubMed ID: 16971975
[TBL] [Abstract][Full Text] [Related]
7. Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Dierckx RA; Jager PL
Int J Cardiovasc Imaging; 2006 Feb; 22(1):63-80. PubMed ID: 16372139
[TBL] [Abstract][Full Text] [Related]
8. Treating the right patient at the right time: access to care in non-ST segment elevation acute coronary syndromes.
O'Neill BJ; Brophy JM; Simpson CS; Sholdice MM; Knutson M; Ross DB; Ross H; Rottger J; Glasgow K;
Can J Cardiol; 2005 Nov; 21(13):1149-55. PubMed ID: 16308588
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT.
Döbert N; Britten M; Assmus B; Berner U; Menzel C; Lehmann R; Hamscho N; Schächinger V; Dimmeler S; Zeiher AM; Grünwald F
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1146-51. PubMed ID: 15064873
[TBL] [Abstract][Full Text] [Related]
10. [Myocardial viability assessment and perioperative cardiovascular evaluation using single photon emission tomography and positron emission tomography].
Yoshinaga K
Kyobu Geka; 2007 Jul; 60(8 Suppl):627-34. PubMed ID: 17763661
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(12):1-38. PubMed ID: 23074389
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18FDG PET with thallium SPECT in the assessment of myocardial viability. A segmental model analysis.
Alexánderson E; Ricalde A; Romero-Ibarra JL; Meave A
Arch Cardiol Mex; 2006; 76(1):9-15. PubMed ID: 16749497
[TBL] [Abstract][Full Text] [Related]
13. Treating the right patient at the right time: access to specialist consultation and non-invasive testing.
Knudtson ML; Beanlands R; Brophy JM; Higginson L; Munt B; Rottger J;
Can J Cardiol; 2006 Aug; 22(10):819-24. PubMed ID: 16957798
[TBL] [Abstract][Full Text] [Related]
14. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387
[TBL] [Abstract][Full Text] [Related]
15. Perceptions of cardiac rehabilitation patients, specialists and rehabilitation programs regarding cardiac rehabilitation wait times.
Grace SL; Tan Y; Marcus L; Dafoe W; Simpson C; Suskin N; Chessex C
BMC Health Serv Res; 2012 Aug; 12():259. PubMed ID: 22897912
[TBL] [Abstract][Full Text] [Related]
16. [Myocardial viability. Study of viability by myocardial scintigraphy].
Pézard P; Jallet P
Presse Med; 1998 Jun; 27(21):1043-9. PubMed ID: 9767828
[TBL] [Abstract][Full Text] [Related]
17. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
[TBL] [Abstract][Full Text] [Related]
18. Treating the right patient at the right time: Access to echocardiography in Canada.
Munt B; O'Neill BJ; Koilpillai C; Gin K; Jue J; Honos G;
Can J Cardiol; 2006 Oct; 22(12):1029-33. PubMed ID: 17036097
[TBL] [Abstract][Full Text] [Related]
19. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
20. Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery.
Graham MM; Knudtson ML; O'Neill BJ; Ross DB;
Can J Cardiol; 2006 Jun; 22(8):679-83. PubMed ID: 16801998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
